Physicians International CT Utilization Registry 2
Big PICTURE 2
Big PICTURE 2: Physicians International CT Utilization Registry 2
1 other identifier
observational
N/A
2 countries
2
Brief Summary
To determine the total plaque burden, plaque severity and composition of patients undergoing Cardiac CT who do not have any previous history of CVD. There are two cohorts:
- 1.A retrospective follow-up for MACE endpoints of patients who underwent a CCTA \>1 year ago as part of the Big PICTURE Trial, who meet the inclusion criteria of Big PICTURE 2.
- 2.A prospective observational registry of patients referred to undergo CCTA with a 1 and 2 year follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2015
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2015
CompletedFirst Posted
Study publicly available on registry
February 3, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedMarch 22, 2017
September 1, 2015
1.8 years
January 29, 2015
March 21, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Plaque characteristics
Total plaque burden, composition, location, severity and myocardial perfusion deficits
Immediately after scan
Secondary Outcomes (1)
MACE endpoints
2 years (or more)
Study Arms (1)
CCTA
Subjects who underwent a CCTA
Interventions
Eligibility Criteria
1000 subjects, 18 or older, no previous CAD
You may qualify if:
- years or older
- No prior CVD
- No hypertension
- No Diabetes
- Body mass index (BMI) \<35 kg/m2.
You may not qualify if:
- \<18 years or older
- Prior CVD
- Hypertension
- Body mass index (BMI) \>=30 kg/m2.
- Diabetes Mellitus Type 1 or 2
- Current or previous history of smoking
- Pregnancy
- Planned intervention or bypass surgery
- Known complex congenital heart disease
- Planned invasive angiography for reasons other than CAD
- Non-cardiac illness with life expectancy \< 2 years
- Inability to provide written informed consent
- Concomitant participation in another clinical trial in which subject is subject to investigational drug or device
- Pregnant women
- Allergy to iodinated contrast agent
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MDDX LLClead
Study Sites (2)
MDDX
San Francisco, California, 94111, United States
FACTS
Hyderabad, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 24 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2015
First Posted
February 3, 2015
Study Start
May 1, 2015
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
March 22, 2017
Record last verified: 2015-09